[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351518-105":59,"doc-detail-351518-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","and-logic-nanoparticle-for-precision-immunotherapy-of-metastatic-cancers","AND logic nanoparticle for precision immunotherapy of metastatic cancers","","Systemic immunotherapy against metastatic cancer depends on tumour-specific immune activation while sparing normal tissues. Single-gate stimulus-responsive systems often fail to discriminate heterogeneous tumour signals from healthy-tissue cues. The study reports an AND-gated nanoparticle requiring acidic pH and hypoxia to activate the STING pathway, using a small-molecule STING agonist linked via a hypoxia-sensitive linker to a pH-sensitive polymer. In immune-cold tumour models, it markedly reduced metastatic burden with minimal systemic toxicity and promoted CD8+ T cell priming and infiltration, synergizing with checkpoint inhibition.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/and-logic-nanoparticle-for-precision-immunotherapy-of-metastatic-cancers/351518/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/and-logic-nanoparticle-for-precision-immunotherapy-of-metastatic-cancers/351518.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are single-gate stimulus-responsive systems inadequate for metastatic cancer immunotherapy?","Question",{"text":112,"@type":113},"They often cannot achieve sufficient tumour specificity because biological signals are heterogeneous and can overlap with signals from normal tissues.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What stimuli does the AND-gated nanoparticle require to activate the STING pathway?",{"text":117,"@type":113},"It requires both acidic pH and hypoxia signals to activate STING.",{"name":119,"@type":110,"acceptedAnswer":120},"What therapeutic effects does the nanoparticle show in metastatic cancer models?",{"text":121,"@type":113},"The treatment significantly reduced metastatic burden while exhibiting minimal systemic toxicity, and it enhanced immune responses via CD8+ T cell priming and infiltration.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351518,1790637897,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","nature nanotechnology  \nArticle [https://doi.org/10.1038/s41565-026-02130-3](https://doi.org/10.1038/s41565-026-02130-3)  \nAND logic nanoparticle for precision immunotherapy of metastatic cancers  \nReceived: 6 February 2025  \nAccepted: 13 January 2026  \n\n| Published online: 9 March 2026 |\n| --- |\n|  Check for updates |\n\nShuyueYe  1,2, Shuang Chen Gang Huang2,3, Mingyi Chen  \n1,2, Vijay Basava2, Katy Torres2, Yangyang Zhao1,2, 4 & Jinming Gao  1,2,3,5   \nSuccess in systemic immunotherapy against metastatic cancer hingeson the ability to achieve tumour-specific immune activation over normal tissues. Single-gate stimuli-responsive systems are not adequate at differentiating tumour versus normal tissue signals. Here we report anAND-gated nanoparticle that requires acidic pHand hypoxia signals to activate the stimulatorof interferon genes (STING) pathway in systemic therapy of metastatic cancers. The dual stimuli-responsive nanoparticle consists of a small-molecule STING agonist conjugated toa pH-sensitive polymer through a hypoxia-sensitive linker. Biochemical analyses confirmed the (pH–hypoxia) AND logic truth table in STING activation. The nanoparticle agonist significantly reduced metastatic burdensin multiple immune-cold tumour models while exhibiting minimal systemic toxicity. Mechanistic investigation revealed that STING activation in tumour-resident type I dendritic cells drives CD8+ T cell priming and infiltration, which synergizes with immune checkpoint inhibitors. This AND logic nanoplatform offers a safe and efficacious therapeutic for STING-mediated immunotherapy against metastatic cancers.  \nMetastatic disease is the leading cause of cancer mortality, accounting for >90% of cancer-related deaths1,2. Conventional treatments (for example, chemotherapy and radiation) provide limited benefit and often cause dose-limiting toxicities3,4. In recent years, immunotherapy has changed the landscape of cancer care by harnessing host immune defence against cancer5. The stimulator of interferon genes (STING) pathway has emerged asa critical component in the activation of innate and adaptive responses in antitumour immunity6,7. Activation of the STING pathway initiatesa signalling cascade that organizes immune cells and promotes a multifaceted type I interferon (I-IFN) response that promotes the maturation and migration of dendritic cells (DCs), and primes cytotoxic T lymphocytes and natural killer (NK) cells against tumour cells8–10. Despite its therapeutic potential, STING-targeted therapies face significant challenges, including poor tumour specificity and the risk of excessive immune activation in healthy tissues11,12.  \nExtensive research has been dedicated to the design and development of stimuli-responsive strategies to improve the safety and antitumour efficacy of cytotoxic drugs13,14. These systems are designed to respond to biological signals that are elevated in tumours over normal tissues15,16. While single stimulus-responsive systems have shown promise, they are often inadequate at achieving high tumour specificity because of the heterogeneous and analogue nature of biological signals17,18. To overcome these challenges, design of nanoparticles (NPs) that requires multiple stimuli signals to achieve intended pharmacological functions may prove useful. In the electronic industry, advances from single-gate transistors to multi-gate logic devices have transformed data transfer and computation19. In chimeric antigen receptor T therapy, logic gate concept has also been introduced in cell circuitry to improve cancer specificity of cytotoxic T cells20.  \nIn this study, we introduce the design and evaluation of a dual stimuli-responsive AND logic NP for systemic STING therapy of  \n1Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, USA. 2Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA. 3Department of Pharmacology, University of ","cbCaiuAN7uMGHWTO","https://ap.wps.com/l/cbCaiuAN7uMGHWTO","pdf",11542041,31,"English","# Background\n## Metastatic disease and limitations of conventional therapy\n## Role and challenges of the STING pathway\n# Rationale for multi-stimulus nanoparticle logic\n## Single-gate vs multi-gate stimulus discrimination\n# Study approach and nanoparticle design\n## Dual stimuli-responsive AND-gated system\n# Experimental screening and therapeutic evaluation\n## Safety, cytokines, and tumour efficacy in metastatic models\n# Mechanistic insights\n## STING activation in dendritic cells and T-cell responses\n# Conclusion\n## Safe and efficacious STING-mediated therapy","[{\"question\":\"Why are single-gate stimulus-responsive systems inadequate for metastatic cancer immunotherapy?\",\"answer\":\"They often cannot achieve sufficient tumour specificity because biological signals are heterogeneous and can overlap with signals from normal tissues.\"},{\"question\":\"What stimuli does the AND-gated nanoparticle require to activate the STING pathway?\",\"answer\":\"It requires both acidic pH and hypoxia signals to activate STING.\"},{\"question\":\"What therapeutic effects does the nanoparticle show in metastatic cancer models?\",\"answer\":\"The treatment significantly reduced metastatic burden while exhibiting minimal systemic toxicity, and it enhanced immune responses via CD8+ T cell priming and infiltration.\"}]","AND logic nanoparticle for precision immunotherapy of metastatic cancers | PDF",1790094540,78,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0960e24fadce47eefdef0f4400635441.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60e6d98d50b67a3702d4e0ed5e47bd39.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45b0896945519d208b502f0b4eb7f838.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ca790c3304e4491f236c36412351b45.webp",980,1301]